about
Treatment of Chagas cardiomyopathyCoronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms.CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973].Developments in the management of Chagas cardiomyopathy.Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathyCaptopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells
P2860
description
article
@en
im Juli 1992 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 1992
@uk
name
Chagas cardiomyopathy and captopril
@en
Chagas cardiomyopathy and captopril
@nl
type
label
Chagas cardiomyopathy and captopril
@en
Chagas cardiomyopathy and captopril
@nl
prefLabel
Chagas cardiomyopathy and captopril
@en
Chagas cardiomyopathy and captopril
@nl
P2093
P1476
Chagas cardiomyopathy and captopril
@en
P2093
E E Martinez
J L Andrade
O P Portugal
R R Roberti
S F Horowitz
V L Araujo
P304
P407
P577
1992-07-01T00:00:00Z